Life Edit Therapeutics
Alishka Garg currently serves as an Associate Scientist II at Life Edit Therapeutics, having started in September 2023. Prior to this role, Alishka was a Bioinformatics Analyst at GreenLight Biosciences, Inc. from June 2021 to September 2023, focusing on the development of bioinformatics pipelines, data analysis, and regulatory submissions. Alishka gained valuable experience as a Student Research Assistant in the McKusick-Nathans Department of Genetic Medicine at Johns Hopkins Medicine, along with roles as a Graduate Assistant and APA Editor at Johns Hopkins University. Earlier positions included internships at Glenmark Pharmaceuticals and Lupin India, where Alishka explored drug development processes and upstream processing in biotechnology. Alishka holds a Master's degree in Biotechnology with a Bioinformatics concentration from Johns Hopkins University and a Bachelor's degree in Biotechnology from Thadomal Shahani Engineering College.
This person is not in the org chart
Life Edit Therapeutics
Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.